Issue link: https://beckershealthcare.uberflip.com/i/731691
14 Hospital Authority. He sits on the boards of March of Dimes, Leadership Academy, QSource and Mid-South e-Health Alliance. Dr. Coopwood was featured in Memphis Magazine's Who's Who in 2010 and he was listed as Memphis Business Journal's Health Care Hero in Administrative Excellence in 2011. Steven J. Corwin, MD. President and CEO of NewYork-Presbyterian Hospital (New York City). Dr. Corwin joined the NewYork-Presbyterian Hospital team in 1979 and filled a variety of leadership roles, including CMO, COO and executive vice president before being named president and CEO in 2011. He is a member of the American Hospital Association's Governing Council of Health Care Systems, the Association of American Medical College's Council of Teaching Hospitals administrative board and the Health Management Academy and is a fellow of the New York Academy of Medicine. Dr. Corwin, a board-certified cardiologist and internist, has served as president of the board of directors of the Great- er New York Hospital Association since June. He has received numer- ous awards, including the Northwestern Alumni Award from Evanston, Ill.-based Northwestern University and the Health Care Industry Good Scout Award from the Boy Scouts of America. Delos (Toby) Cosgrove, MD. President and CEO of Cleveland Clinic. Dr. Cosgrove joined the Cleveland Clinic family in 1975 and has served as president and CEO of the $8 billion health system since 2004. He over- sees the Cleveland Clinic, nine regional hospitals and 21 family health and ambulatory surgery centers, as well as hospitals in Las Vegas, Toron- to and Abu Dhabi. Prior to his time at Cleveland Clinic, Dr. Cosgrove served as a surgeon in the U.S. Air Force and chief of U.S. Air Force Ca- sualty Staging Flight in Da Nang, Republic of Vietnam. He is the recipi- ent of multiple Cleveland Clinic awards, including the Master Clinician Award, Innovator of the Year Award and Lerner Humanitarian Award. He is a member of the Cleveland Medical Hall of Fame and Cleveland Business Hall of Fame. He has performed more than 22,000 operations and published 450 journal articles, numerous book chapters, 17 medical education videos and one book. Kenneth L. Davis, MD. President and CEO of Mount Sinai Health System (New York City). Dr. Davis was named president and CEO of the Mount Sinai Medical Center in 2003. He entered his current role in 2013 when the medical center merged with Continuum Health Partners' hospitals, which include Beth Israel Medical Center and St. Luke's and Roosevelt hospitals in New York City. Dr. Davis served as dean of Mount Sinai School of Medicine from 2003 to 2007. He was chair of the school's department of psychiatry for 15 years and a founding director for many of the institution's research entities. Dr. Davis' research efforts led to the regulatory approval for three out of the four first drug treatments for Alz- heimer's. Dr. Davis was elected to the Institute of Medicine of the Nation- al Academy of Science in 2002 and served as president of the American College of Neuropsychopharmacology in 2006. Ralph de la Torre, MD. Chairman and CEO of Steward Health Care System (Boston, Mass.). As chairman and CEO of Steward Health Care System, Dr. de la Torre oversees a $2.4 billion system that includes 3,000 physicians, 24 affiliated urgent care providers, 10 hospital campuses, six ambulatory surgery centers, home care and hospice, among other ser- vices. Under his leadership, Steward Health Care System grew into the fourth largest employer in Massachusetts and New England's largest community care company. Prior to his role at Steward, he was founder and CEO of the Cardiovascular Institute at Beth Israel Deaconess Med- ical Center in Boston and Cardiovascular Management Associates, one of the first totally integrated systems for treating cardiac patients in the U.S. He also served as chief of cardiac surgery and was part of Harvard Medical Faculty Physicians at BIDMC. Ronald DePinho, MD. President of the University of Texas MD An- derson Cancer Center (Houston). Prior to his appointment as president of MD Anderson Cancer Center in September 2011, Dr. DePinho spent 14 years at Dana-Farber Cancer Institute in Boston where he served as founding director of the Belfer Institute for Applied Cancer Science. He was a genetics professor in the department of medicine at Harvard Uni- versity School of Medicine in Boston and an American Cancer Society research professor. He has also held numerous faculty positions at the Albert Einstein College of Medicine in New York City, where he was the Feinberg Senior Scholar in Cancer Research. Dr. DePinho sat on the board of directors of the American Association for Cancer Research, co-founded numerous biotech companies and is internationally recog- nized for his contributions to basic and translational research in cancer, aging and age-associated degenerative disorders. James R. Downing, MD. President and CEO of St. Jude's Research Hos- pital (Memphis, Tenn.). Dr. Downing joined St. Jude's in 1986, serving as deputy director, executive vice president and scientific director before being named president and CEO in 2014. In addition to his role as president and CEO, he sits on a Blue Ribbon Panel to advise Vice President Joe Biden's National Cancer Moonshot Initiative through the National Cancer Institute. Dr. Downing played an instrumental role in launching the Pediatric Cancer Genome Project, which led to groundbreaking discoveries in the field of cancer and made Time magazine's 2012 list of top 10 medical breakthroughs. In 2013, he was elected to the Institute of Medicine and named a finalist in Time magazine's 100 Most Influential People list. He has received numerous awards, including the Association for Molecular Pathology Award for Excel- lence in Molecular Diagnostics. Reginald J. Eadie, MD. CEO of DMC Detroit Receiving Hospital, DMC Harper University Hospital and DMC Hutzel Women's Hospital (Detroit). Dr. Eadie first joined the Detroit Medical Center staff in 1998 for his residency in emergency medicine at Detroit Receiving Hospital. He has filled a variety of leadership roles at the health system, including vice president of medical affairs at DMC Harper University Hospital and Hutzel Women's Hospital, president of DMC Sinai-Grace Hospital and Detroit Receiving Hospital and CEO of DMC Harper-Hutzel Hospital. Dr. Eadie served as emergency department chief and associate chief of staff of integrated clinical services at the John D. Dingell VA Medical Center in Detroit. He is a diplomat of the American Board of Emergency Medicine and a member of the America College of Healthcare Execu- tives. Susan Ehrlich, MD. CEO of Priscilla Chan and Mark Zuckerberg San Francisco General Hospital and Trauma Center. Before joining Zuck- erberg San Francisco General as CEO in April, Dr. Ehrlich held a variety of roles at the San Mateo (Calif.) Medical Center over the course of nearly 14 years, beginning as a staff physician in 2002. Later, she served as CMO, vice president and medical director. Most recently she served as CEO since 2009. Dr. Ehrlich also previously served as budget and planning director for the San Francisco Department of Public Health. In her role at Zuckerberg San Francisco General, Dr. Ehrlich leads a staff and UCSF faculty of 5,400 people and oversees the hospital's $1.1 billion budget. Melinda Estes, MD. President and CEO of Saint Luke's Health System (Kansas City, Mo.). Dr. Estes was named president and CEO of 10-hos- pital Saint Luke's Health System in 2011. Formerly, she served as presi- dent and CEO of Fletcher Allen Health Care in Burlington, Vt. She also spent almost 20 years at Cleveland Clinic in a variety of leadership and administrative roles and acted as senior vice president of medical affairs and executive vice president of MetroHealth System in Cleveland. Dr. Es- tes has held professorships in pathology at University of Vermont College of Medicine in Burlington, Case Western Reserve University School of Medicine in Cleveland and Columbus-based the Ohio State University College of Medicine. She is a board-certified neurologist and neuropa- thologist who has published numerous book chapters and more than 100 scientific research papers. David Feinberg, MD. President and CEO of Geisinger Health System (Danville, Pa.). Dr. Feinberg has been president and CEO of Geisinger